Survival Outcomes for Patients in the QUAZAR AML-001 Trial Who Received Subsequent Therapy for Acute Myeloid Leukemia (AML) after Discontinuing Oral Azacitidine or Placebo
| Autor: | Ravandi, Farhad, Montesinos, Pau *, Pfeilstöcker, Michael *, Papayannidis, Cristina, Dombret, Hervé, Lai, Yinzhi *, Petrlik, Erica *, Prebet, Thomas *, Döhner, Hartmut |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:3277-3279 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|